Cluster for Nucleic Acid Therapeutics Munich

The IPT is part of the Cluster for Nucleic Acid Therapeutics Munich (CNATM)(link is external). CNATM is on of the 14 winners of the Clusters4Future initiative of the German Ministry for Education and Research (BMBF). The research consortium consists of research groups from the leading universities LMU and TU, researchers from the universities of Regensburg and Würzburg, as well as the Helmholtz center Munich, and 14 industrial partners from the Munich area.

CNATM is creating a network from which novel nucleic acid-based active substances and next-generation vaccines are to be developed.The ability to design nucleic acids in a highly specific and theoretically predictable way opens up completely new therapeutic approaches in medicine.